Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Development of Osteoarthritis Accelerated by Molecular Changes in the Bones

By LabMedica International staff writers
Posted on 28 May 2013
Development of osteoarthritis, a disease of the joints caused by degeneration of the cartilage, may depend as much on molecular changes in the underlying bone as it does on injury sustained by the cartilage.

Osteoarthritis is a highly prevalent and debilitating joint disorder thought to originate from instability in the load-bearing joints of the knee and hip caused by injury or strain. More...
There is no effective medical therapy for the condition because of limited understanding of its pathogenesis.

Investigators at Johns Hopkins University (Baltimore, MD, USA) felt that development of osteoarthritis must also be related to the changes in the underlying bone. To study this concept they worked with both bone cell cultures and a mouse osteoarthritis model.

They reported in the May 19, 2013, online edition of the journal Nature Medicine that ligament injury triggered damage in the subchondral bone that activated high levels of TGF-beta1 (transforming growth factor-beta1) protein, which recruited stem cells to the site so that they could create new bone to repair the damage. The additional bone stressed the cartilage above it and increased the rate of cartilage deterioration.

In the mouse model, it was seen that transgenic expression of active TGF-beta1 in osteoblastic cells induced osteoarthritis, whereas inhibition of TGF-beta activity in subchondral bone attenuated cartilage degeneration. In particular, knockout of the TGF-beta type II receptor (TbetaRII) led to less development of osteoarthritis relative to wild-type mice.

"If there is something wrong with the leg of your chair and you try to fix it by replacing the cushion, you have not solved the problem," said senior author Dr. Xu Cao, professor of orthopedic surgery at Johns Hopkins University. "We think that the problem in osteoarthritis is not just the cartilage "cushion,” but the subchondral bone underneath. That helped us to see the ways in which the bone was responding to changes in the cartilage and exacerbating the problem."

"Our results are potentially really good news for patients with osteoarthritis," said Dr. Cao. "We are already working to develop a clinical trial to test the efficacy of locally applied TGF-beta1 antibodies in human patients at early stages of osteoarthritis. If successful, this nonsurgical treatment could make osteoarthritis - and the pain and debilitation it causes - halt in its tracks."

Related Links:
Johns Hopkins University




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.